ArticleJournal of microbiology and biotechnology2024

Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways.

Limin Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.